Atossa Therapeutics Inc (NASDAQ: ATOS) is 85.23% higher on its value in year-to-date trading and has touched a low of $0.59 and a high of $1.57 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ATOS stock was last observed hovering at around $1.55 in the last trading session, with the day’s gains setting it 0.08%.
Currently trading at $1.63, the stock is 45.04% and 65.33% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.79 million and changing 5.16% at the moment leaves the stock 82.54% off its SMA200. ATOS registered 148.85% gain for a year compared to 6-month gain of 105.37%. The firm has a 200-day simple moving average (SMA200) of -$3.62.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 59.80% loss in the last 1 month and extending the period to 3 months gives it a 126.36%, and is 29.37% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.23% over the week and 9.77% over the month.
Atossa Therapeutics Inc (ATOS) has around 11 employees, a market worth around $204.24M and $0.00M in sales. Distance from 52-week low is 176.22% and 3.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-30.36%).
Atossa Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$0.06.The EPS is expected to shrink by -14.29% this year
54 institutions hold shares in Atossa Therapeutics Inc (ATOS), with institutional investors hold 13.00% of the company’s shares. The shares outstanding are 126.62M, and float is at 125.28M with Short Float at 5.71%. Institutions hold 13.00% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 5.68 million shares valued at $9.25 million. The investor’s holdings represent 4.53% of the ATOS Shares outstanding. As of Dec 30, 2023, the second largest holder is Blackrock Inc. with 2.8 million shares valued at $4.56 million to account for 2.23% of the shares outstanding. The other top investors are Laurion Capital Management, LP which holds 2.23 million shares representing 1.78% and valued at over $3.63 million, while Renaissance Technologies, LLC holds 1.02% of the shares totaling 1.28 million with a market value of $2.09 million.
Atossa Therapeutics Inc (ATOS) Insider Activity
The most recent transaction is an insider sale by WEAVER GREGORY L, the company’s Former EVP, CFO, & Director. SEC filings show that WEAVER GREGORY L sold 50,000 shares of the company’s common stock on Nov 15 ’23 at a price of $0.65 per share for a total of $32500.0. Following the sale, the insider now owns 55.0 shares.
